Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study

By Son Byung  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1143-1152

Springer Publishing Company

Access to resources Recommend Favorite

Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients

By Hautala Laura   Greco Dario   Koistinen Riitta   Heikkinen Tuomas   Heikkilä Päivi   Aittomäki Kristiina   Blomqvist Carl   Koistinen Hannu   Nevanlinna Heli  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 85-95

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 Mutations in Patients with Familial Risk of Breast Cancer

By Garcia-Patiño Elena   Gomendio Blanca   Silva Jose M.   Garcia Jose M.   Provencio Mariano   España Pilar   Bonilla Felix  

Acta Oncologica, Vol. 37, Iss. 3, 1998-07 ,pp. : 299-300

Informa Healthcare

Access to resources Recommend Favorite

Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

By Gershoni-Baruch R.   Dagan E.   Fried G.   Bruchim Bar-Sade R.   Sverdlov-Shiri R.   Zelicksson G.   Friedman E.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 983-986

Elsevier

Access to resources Recommend Favorite

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil

By Gomes Magda   Costa Mauricio   Borojevic Radovan   Monteiro Alvaro   Vieira Roberto   Koifman Sergio   Koifman Rosalina   Li Song   Royer Robert   Zhang Shiyu   Narod Steven  

Breast Cancer Research and Treatment, Vol. 103, Iss. 3, 2007-07 ,pp. : 349-353

Springer Publishing Company

Access to resources Recommend Favorite